에스토니아 - 에스토니아어 - Ravimiamet

lex ano uab - tsetirisiin - suukaudsed tilgad, lahus - 10mg 1ml 20ml 1tk

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

albireo - odevixibat - cholestasis, intrahepatic - vere ja maksa ravi - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 ja 5.

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

serb sas - glucarpidase - metabolic side effects of drugs and substances - kõik muud ravitoimingud - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

에스토니아 - 에스토니아어 - Adama

adama - vees dispergeeruvad graanulid - tribenuroon-metüül - herbitsiidid